<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>17(10)</volume><submitter>Rios P</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The Renal Healthcare Program Uruguay (NRHP-UY) is a national, multidisciplinary program that provides care to chronic kidney disease (CKD) patients. In this study, we report the global results of CKD patient outcomes and a comparison between those treated at the NRHP-UY Units, with those patients who were initially included in the program but did not adhere to follow up.&lt;h4>Methods&lt;/h4>A cohort of not-on dialysis CKD patients included prospectively in the NRHP-UY between October 1st 2004 and September 30th 2017 was followed-up until September 30th 2019. Two groups were compared: a) Nephrocare Group: Patients who had at least one clinic visit during the first year on NRHP-UY (n = 11174) and b) Non-adherent Group: Patients who were informed and accepted to be included but had no subsequent data registered after admission (n = 3485). The study was approved by the Ethics Committee and all patients signed an informed consent. Outcomes were studied with Logistic and Cox´s regression analysis, Fine and Gray competitive risk and propensity-score matching tests.&lt;h4>Results&lt;/h4>14659 patients were analyzed, median age 70 (60-77) years, 56.9% male. The Nephrocare Group showed improved achievement of therapeutic goals, ESKD was more frequent (HR 2.081, CI 95%1.722-2.514) as planned kidney replacement therapy (KRT) start (OR 2.494, CI95% 1.591-3.910), but mortality and the combined event (death and ESKD) were less frequent (HR 0.671, CI95% 0.628-0.717 and 0.777, CI95% 0.731-0.827) (p = 0.000) compared to the Non-adherent group. Results were similar in the propensity-matched group: ESKD (HR 2.041, CI95% 1.643-2.534); planned kidney replacement therapy (KRT) start (OR 2.191, CI95% 1.322-3.631) death (HR 0.692, CI95% 0.637-0.753); combined event (HR 0.801, CI95% 0.742-0.865) (p = 0.000).&lt;h4>Conclusion&lt;/h4>Multidisciplinary care within the NRHP-UY is associated with timely initiation of KRT and lower mortality in single outcomes, combined analysis, and propensity-matched analysis.</pubmed_abstract><journal>PloS one</journal><pagination>e0266617</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9565398</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes.</pubmed_title><pmcid>PMC9565398</pmcid><pubmed_authors>Ceretta L</pubmed_authors><pubmed_authors>Rios P</pubmed_authors><pubmed_authors>Silvarino R</pubmed_authors><pubmed_authors>all nephrologists who report to Programa de Salud Renal Uruguay Registry</pubmed_authors><pubmed_authors>Gadola L</pubmed_authors><pubmed_authors>Ferreiro A</pubmed_authors><pubmed_authors>Lamadrid V</pubmed_authors><pubmed_authors>Sola L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Adherence to multidisciplinary care in a prospective chronic kidney disease cohort is associated with better outcomes.</name><description>&lt;h4>Introduction&lt;/h4>The Renal Healthcare Program Uruguay (NRHP-UY) is a national, multidisciplinary program that provides care to chronic kidney disease (CKD) patients. In this study, we report the global results of CKD patient outcomes and a comparison between those treated at the NRHP-UY Units, with those patients who were initially included in the program but did not adhere to follow up.&lt;h4>Methods&lt;/h4>A cohort of not-on dialysis CKD patients included prospectively in the NRHP-UY between October 1st 2004 and September 30th 2017 was followed-up until September 30th 2019. Two groups were compared: a) Nephrocare Group: Patients who had at least one clinic visit during the first year on NRHP-UY (n = 11174) and b) Non-adherent Group: Patients who were informed and accepted to be included but had no subsequent data registered after admission (n = 3485). The study was approved by the Ethics Committee and all patients signed an informed consent. Outcomes were studied with Logistic and Cox´s regression analysis, Fine and Gray competitive risk and propensity-score matching tests.&lt;h4>Results&lt;/h4>14659 patients were analyzed, median age 70 (60-77) years, 56.9% male. The Nephrocare Group showed improved achievement of therapeutic goals, ESKD was more frequent (HR 2.081, CI 95%1.722-2.514) as planned kidney replacement therapy (KRT) start (OR 2.494, CI95% 1.591-3.910), but mortality and the combined event (death and ESKD) were less frequent (HR 0.671, CI95% 0.628-0.717 and 0.777, CI95% 0.731-0.827) (p = 0.000) compared to the Non-adherent group. Results were similar in the propensity-matched group: ESKD (HR 2.041, CI95% 1.643-2.534); planned kidney replacement therapy (KRT) start (OR 2.191, CI95% 1.322-3.631) death (HR 0.692, CI95% 0.637-0.753); combined event (HR 0.801, CI95% 0.742-0.865) (p = 0.000).&lt;h4>Conclusion&lt;/h4>Multidisciplinary care within the NRHP-UY is associated with timely initiation of KRT and lower mortality in single outcomes, combined analysis, and propensity-matched analysis.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2024-11-06T04:32:06.165Z</modification><creation>2024-11-06T04:32:06.165Z</creation></dates><accession>S-EPMC9565398</accession><cross_references><pubmed>36240220</pubmed><doi>10.1371/journal.pone.0266617</doi></cross_references></HashMap>